Two Sigma Securities »

Bolt Biotherapeutics shares owned by Two Sigma Securities

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Two Sigma Securities from 13F filings

Historical chart of Two Sigma Securities investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Two Sigma Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Two Sigma Securities

Quarter filed Position value Share count Share price at filing
2024-06-30 $40k 54k 0.75
2024-03-31 $33k 24k 1.40
2023-12-31 $72k 64k 1.12

More positions owned by Two Sigma Securities

NVIDIA Corporation Call Option (NVDA)
Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Advanced Micro Devices (AMD)
Microsoft Corporation Call Option (MSFT)
Intel Corporation Call Option (INTC)
Eli Lilly & Co. Call Option (LLY)
Johnson & Johnson (JNJ)
JPMorgan Chase & Co. (JPM)
Tesla Motors (TSLA)
Palo Alto Networks Call Option (PANW)
Chevron Corporation Call Option (CVX)
Amazon (AMZN)
Costco Wholesale Corporation Call Option (COST)

View all positions for Two Sigma Securities

Top funds holding Bolt Biotherapeutics

Tang Capital Management
Sofinnova Ventures
Pivotal bioVenture Partners Investment Advisor
Nan Fung Group Holdings
Vanguard Group
Samsara BioCapital
Board of Trustees of The Leland Stanford Junior University
Newtyn Management
Geode Capital Management
Renaissance Technologies
BlackRock
BlackRock
Susquehanna International
Bridgeway Capital Management
Two Sigma Securities

View all funds holding Bolt Biotherapeutics